Decision Resources finds that the type 2 diabetes drug market will nearly double over the next decade, increasing from $26 billion in 2011 to nearly $50 billion in 2021 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. The main factors fueling this growth are an...